|
Thermo Fisher
gene exp birc3 hs00154109 m1 ![]() Gene Exp Birc3 Hs00154109 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/gene exp birc3 hs00154109 m1/product/Thermo Fisher Average 91 stars, based on 1 article reviews
gene exp birc3 hs00154109 m1 - by Bioz Stars,
2026-05
91/100 stars
|
Buy from Supplier |
|
Bioss
api2 polyclonal antibody ![]() Api2 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/api2 polyclonal antibody/product/Bioss Average 90 stars, based on 1 article reviews
api2 polyclonal antibody - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
birc3 ![]() Birc3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/birc3/product/Cell Signaling Technology Inc Average 95 stars, based on 1 article reviews
birc3 - by Bioz Stars,
2026-05
95/100 stars
|
Buy from Supplier |
|
Thermo Fisher
gene exp birc3 hs00985030 g1 ![]() Gene Exp Birc3 Hs00985030 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/gene exp birc3 hs00985030 g1/product/Thermo Fisher Average 93 stars, based on 1 article reviews
gene exp birc3 hs00985030 g1 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Proteintech
birc3 ![]() Birc3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/birc3/product/Proteintech Average 93 stars, based on 1 article reviews
birc3 - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Mean (logRQ ± SE) expression of BIRC3 and XAF1 genes depending on PD-1 expression, The U Mann Whitney Test.
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing, MANN-WHITNEY
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Mean (logRQ ± SE) expression of BIRC2 (p = 0.025) , BIRC3 and BIRC5 genes depending on survival rate (< 20 months and > 20 months), (The U Mann Whitney Test)
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing, MANN-WHITNEY
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Mean (logRQ ± SE) expression of BIRC2 and BIRC3 genes depending on survival rate (< 12 months and > 12 months), (The U Mann Whitney Test)
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing, MANN-WHITNEY
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Scatterplot between BIRC2 gene expression (logRQ) and survival rate ( r = -0.478 p < 0.05 Spearman’s rank correlations).
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Gene Expression
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Scatterplot between BIRC3 gene expression (logRQ) and survival rate ( r = -0.536 p < 0.05 Spearman’s rank correlations).
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Gene Expression
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Mean (logRQ ± SE) expression of BIRC2 and BIRC3 genes depending on progression free survival (< 20 months and > 20 months), (The U Mann Whitney Test)
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing, MANN-WHITNEY
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Scatterplot between BIRC2 gene expression (logRQ) and progression-free survival ( r =-0.481 p < 0.05 Spearman’s rank correlations).
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Gene Expression
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Mean (logRQ ± SE) expression of BIRC2 and BIRC3 genes depending on progression-free survival (< 12 months and > 12 months), (The U Mann Whitney Test)
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing, MANN-WHITNEY
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Scatterplot between BIRC3 gene expression (logRQ) and progression-free survival ( r =-0.536 p < 0.05 Spearman’s rank correlations).
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Gene Expression
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Forest plot of odds ratios (OR) from univariate logistic regression for dichotomized survival endpoints (OS/PFS) in the intersection set, using BIRC2 expression (logRQ) as predictor.
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Forest plot of odds ratios (OR) from univariate logistic regression for dichotomized survival endpoints (OS/PFS) in the intersection set, using BIRC3 expression (logRQ) as predictor.
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Kaplan–Meier overall survival stratified by BIRC2 expression group (high vs. low). Log-rank p = 0.023* BIRC2 group (high = logRQ BIRC2 >-0.077794 (median) /low = logRQ BIRC2 <=-0.077794).
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing
Journal: Scientific Reports
Article Title: Reduced expression of BIRC2 and BIRC3 associated with longer survival in pediatric high-grade gliomas
doi: 10.1038/s41598-026-35887-7
Figure Lengend Snippet: Kaplan–Meier overall survival stratified by BIRC3 expression group (high vs. low). Log-rank p = 0.1824. BIRC3 group (high = logRQ BIRC3 >-0.316210 (median) /low = logRQ BIRC3 <=-0.316210).
Article Snippet: The following TaqMan probes were used for the reaction: NAIP (Hs03037952_m1), BIRC2 (Hs00357350_m1), BIRC3 (
Techniques: Expressing
Journal: Scientific Reports
Article Title: Proteomics analysis reveals progesterone receptor induced mitochondria-mediated apoptosis in breast cancer cells
doi: 10.1038/s41598-025-28183-3
Figure Lengend Snippet: Examples of PR regulated proteins and pathways involved in cell proliferation and apoptosis. The quantitative proteomic analysis identified significant changes of thousands of proteins and many hundreds of phosphorylated peptides in response to PR agonist. This figure shows proteins and pathways that were analyzed and interpreted in greater details. (A) Proteins and complexes involved in R5020 induced G0/G1 and G2/M cell cycle arrest, which could also be triggers for apoptosis. (B) PR regulated mitochondrial proteins involved in R5020 induced apoptosis. Significant increases of HIF1A and its downstream targets such as BNIP3 and NIX activated mitophagy together with upregulated LC3. Prolonged increase of BNIP3 and NIX causes mitochondria dysfunction and loss of mitochondria membrane potential. BNIP3 and NIX can sequester anti-apoptotic proteins such as BCL-2 and BCL-XL. This relieved BH3-only proteins, which facilitated formation of BAX and BAK pores on mitochondria outer membrane, leading to MOMPs, cytochrome c release and CASP9 activation, along with upregulation and releases of pro-apoptotic factors such as AIF, ENDOG, HtrA2/Omi, and Smac/DIABLO. PR induced apoptotic mechanism may also involve some of the 200 mitochondrial proteins regulated by R5020. (C) p53 pathway may also participate in R5020-induced cell apoptosis through upregulation of proteins such as death receptors FAS, DR4 and DR5. Upregulation of MDM2 is involved in a negative feedback regulation of p53. (D) TNF signaling via NFKB is generally pro-survival. It was found to be markedly upregulated. Gene silencing of its key players BIRC3 and TNFAIP3 alone or in combination had no influence on R5020 induced downregulation of effector caspases and apoptosis. (E) True to the holistic nature of proteomic analysis, the study also detected the previously reported upregulation of protooncogenic proteins by R5020, but the upregulation of these proteins are futile and should not be interpreted as evidence for pro-tumoral activity of PR. Additionally, all effector CASPs detected in the MS data and in immunoblots were downregulation despite R5020 induced apoptosis. *Although CASP6 is marginally increased in MS data and immunoblot, its activation by cleavage is evidently reduced in immunoblot. Blue downward arrow = Downregulation; Red upward arrow = Upregulation.
Article Snippet:
Techniques: Membrane, Activation Assay, Activity Assay, Western Blot
Journal: BMC Cancer
Article Title: Chidamide impedes glycolysis but increases ferroptosis and cisplatin sensitivity of lung cancer cells through downregulating USP35
doi: 10.1186/s12885-025-14925-z
Figure Lengend Snippet: Chidamide regulated the proteins associated with glycolysis, ferroptosis and DDP sensitivity by down-regulating USP35. A549 cells with treatment of 0.8 µM chidamide and H460 cells with treatment of 3.2 µM chidamide or not were transfected with oe-NC or oe-USP35. A - D WB analysis ( A ) was administrated for protein examination of PKM2 ( B ), FPN ( C ), and BIRC3 ( D ) in A549 cells. E - H WB results ( E ) for PKM2 ( F ), FPN ( G ), and BIRC3 ( H ) in H460 cells. */# P < 0.05, **/##/&& P < 0.01, ***/###/&&& P < 0.001. * : compared to oe-NC group, # : compared to oe-USP35 group, & : compared to chidamide + oe-NC group
Article Snippet: The primary antibodies against USP35 (proteintech, Wuhan, China, 24559-1-AP), PKM2 (proteintech, 15822-1-AP), FPN (proteintech, 26601-1-AP),
Techniques: Transfection